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Abstract InsuYcient blood supply during acute infarc-
tion and chronic ischemia leads to tissue hypoxia which
can signiWcantly alter gene expression patterns in the
heart. In contrast to most mammals, some teleost Wshes
are able to adapt to extremely low oxygen levels. We
describe here that chronic constant hypoxia (CCH) leads
to a smaller ventricular outXow tract, reduced lacunae
within the central ventricular cavity and around the tra-
beculae and an increase in the number of cardiac myo-
cyte nuclei per area in the hearts of two teleost species,
zebraWsh (Danio rerio) and cichlids (Haplochromis
piceatus). In order to identify the molecular basis for the
adaptations to CCH, we proWled the gene expression
changes in the hearts of adult zebraWsh. We have ana-
lyzed over 15,000 diVerent transcripts and found 376
diVerentially regulated genes, of which 260 genes
showed increased and 116 genes decreased expression
levels. Two notch receptors (notch-2 and notch-3) as
well as regulatory genes linked to cell proliferation were
transcriptionally upregulated in hypoxic hearts. We
observed a simultaneous increase in expression of IGF-2
and IGFbp1 and upregulation of several genes important
for the protection against reactive oxygen species
(ROS). We have identiWed here many novel genes
involved in the response to CCH in the heart, which may
have potential clinical implications in the future.
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Introduction
Low oxygen levels (hypoxia) play important roles in
clinical conditions such as stroke and heart failure.
InsuYcient blood supply leads to tissue hypoxia in
the heart during acute infarction and chronic ischemia
(Semenza 2001).
EVective protection of the heart against ischemia/
reperfusion injury is one of the most important goals of
experimental and clinical research in cardiology.
Besides ischemic preconditioning as a powerful tempo-
ral protective phenomenon, adaptation to chronic
hypoxia also increases cardiac tolerance to all major del-
eterious consequences of acute oxygen deprivation such
as myocardial infarction, contractile dysfunction and
ventricular arrhythmias (Kolar and Ostadal 2003).
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Although many factors have been proposed to play
potential roles, the detailed mechanism of this long-term
protection remains poorly understood. Some of the
molecular mechanisms of cardiac protection by adapta-
tion to chronic hypoxia and chronic high-altitude
hypoxia have recently been reviewed (Kolar and Ostadal
2003; Ostadal and Kolar 2007). KATP channels, PKC as
well as the diVerent MAPK pathways were shown to be
involved in the mechanism of increased tolerance of
chronically hypoxic hearts and further the controversial
role of ROS in hypoxia tolerance is discussed (Kolar and
Ostadal 2003). Furthermore, a recent study has proWled
the gene expression changes induced by chronic constant
hypoxia (CCH) and chronic intermittent hypoxia (CIH)
in newborn mice (Fan et al. 2005).
In contrast to most mammals (with the exception of
some marine mammals), some teleosts, have developed the
ability to withstand extreme chronic hypoxia (Stecyk et al.
2004). It is well assumed that these vertebrate species pos-
sess unique adaptations in order to survive short and long
term oxygen deprivation. However, the molecular basis of
these adaptations in Wsh has so far not been extensively
investigated.
Several studies have proWled gene expression changes
in teleosts exposed to hypoxia. Gracey et al. showed in
adults of the euryoxic gobiid Wsh  Gillichthys mirabilis
(the long-jawed mudsucker), that 5 days of hypoxia
induced a complex transcriptional response, including a
shut down of energy requiring pathways like protein
synthesis and locomotion, and an induction of genes
needed for anaerobic ATP production in diVerent tissues
(Gracey et al. 2001). Recently, we described phenotypic
and behavioral adaptations to long-term hypoxia and
described the gene expression changes induced by chronic
constant hypoxia in the gills of adult zebraWsh (van der
Meer et al. 2005).
Ton et al. identiWed global gene expression changes in
zebraWsh embryos. ZebraWsh embryos at 48 h post fertiliza-
tion were exposed to water with 5% oxygen content for
24 h. The authors identiWed 138 genes responsive to short-
term hypoxia and could also show that transcriptional
changes indicated metabolic depression, a switch from aer-
obic to anaerobic metabolism and energy conservation
(Ton et al. 2003).
In this study, we have identiWed CCH-induced gene
expression changes in the zebraWsh heart by looking at
over half of the zebraWsh genome. We have compared
several of these novel changes described in other species
and tissues. We have here identiWed the heart-speciWc
molecular adaptations to CCH. Future functional experi-
ments are warranted to determine whether some of the
Wndings can be used to better adapt mammalian hearts to
CCH.
Material and methods
Animal handling
Adult wild-type zebraWsh (Danio rerio) around 3 month of
age, were obtained from a local pet store. Cichlids
(Haplochromis piceatus) have been collected in the
Mwanza Gulf of Lake Victoria in 1984 and were bred in
our laboratory for about 20 generations. All animals were
handled in compliance with animal care regulations. Our
animal protocols were approved by the review board of
Leiden University in accordance with the requirements of
the Dutch government. ZebraWsh were kept at 25°C in
aquaria with day/night light cycles (12 h dark vs. 12 h
light). Cichlids were kept at 25°C with the same day/night
light cycles.
Hypoxia treatment
For gradual hypoxia treatment, oxygen levels were gradu-
ally decreased in 4 days from 100% air saturated water to
40% (day 1), 30% (day 2), 20% (day 3) and the Wnal 10%
air saturation (day 4). After day 4, the Wsh were kept for an
additional 21 days at 10% air saturation. (at 100% air satu-
ration and 28°C the O2 concentration is 8 mg/l and pO2 is
15 Torr). In parallel, a control group was kept at 100% air
saturated water. Both groups were kept in identical aquaria
of 100 l. The oxygen level on the hypoxia group was kept
constant by a controller (Applikon Biotechnology, The
Netherlands) connected to an O2-electrode and solenoid
valve in line with an air diVuser. The oxygen level in the
tank was kept constant by adding oxygen via the diVuser
and thereby compensating the oxygen consumption of the
Wsh. In case of immediate hypoxia exposure, tanks were
pre-equilibrated to the respective pO2 concentration and
Wsh were then directly set in the equilibrated aquaria.
Perfusion of cichlid hearts
In order to minimize blood clotting, a perfusion protocol
was developed in which the whole blood volume of clini-
cally dead animals was initially replaced with isotonic
buVer and with a Wxative solution secondarily.
Heart dissection
The Wsh were killed with an overdose of anesthetic (MS-222;
Tricaine Methanesulfonate from Argent Chemical Labo-
ratories, USA). Hearts were dissected from the Wsh
immediately after the anesthetic worked. For RNA prep-
aration the hearts were immediately shock-freezed in
liquid nitrogen. For histology and microscopy, the hearts
were left intact and Wxed immediately in KarnovskyJ Comp Physiol B (2008) 178:77–92 79
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Wxative (4% paraformaldehyde (PFA) and 2.5% glutar-
aldehyde in 0.1 M phosphate buVer, pH 7.2) for 4 h at
4°C. After three washes in 0.1 M phosphate buVer, pH
7.2, they were transferred to 70% ethanol.
Histology of adult Wsh hearts, statistical analysis 
and scanning electron microscopy
Hearts from zebraWsh and cichlids raised either under
normoxic or hypoxic conditions, were dissected from the
Wsh and Wxed for 24 h in 4% PFA in PBS. After Wxation,
hearts were washed with 1 £ PBS, cut in halfs (sagittal
through the midline) and then dehydrated through ethanol
series starting at 70% ethanol, followed by 80, 90, 96 and
100% ethanol, each step was done once for 1 h except the
last one which was done twice. After dehydration the hearts
were embedded in increasing gradients of Historesin (Tech-
novit 7100, Heraus Kulzer, Germany) (25, 50, 75 and 100%
Historesin in ethanol, for 2 h at room temperature; 100%
Historesin, 24 h at 4°C). Afterwards the plastic with the
hearts was polymerized at 40°C (overnight). A 5 m sagit-
tal sections were made using the Ultramicrotome (Reichter-
Jung) and a glass knife. Approximately 500 sections on
each side of the midline were visually analyzed per heart
(1,000 sections in total per heart). Sections were left to dry
and later stained with hematoxylin–eosin staining. Pictures
were taken with Axioplan 2 imaging, (Carl Zeiss, Jena).
Azan staining of histological sections were done as follows.
ParaYn sections of the hearts were prepared as described
before (van der Meer et al. 2006). Sections were incubated
with Azokarmine solution, for 30 min at 60°C. Afterwards
they were washed in water and diVerentiated in 0.2% Anilin
alcohol. They were then rinsed in 1% acetic acid in 95%
alcohol, followed by 45 min incubation period, in 5% phos-
photungstic acid. After that, sections were rinsed in dis-
tilled water and incubated for 45 min with aniline blue.
Finally, they were rinsed with distilled water, diVerentiated
and dehydrated in 95% alcohol followed by absolute,
cleared in xylene and mounted in Entallan. The protocols
used here for SEM had been described before (van der
Meer et al. 2005). The statistical analysis of cardiac myo-
cyte nuclei per section was done using Statistica by per-
forming an independent t test. A P value of less than 0.05
was considered signiWcant.
Immunohistochemistry and statistical analysis
ZebraWsh, raised either under normoxic or hypoxic condi-
tions, were killed with an overdose of anesthetic MS-222
and frozen in liquid nitrogen. Subsequently, transversal
cross-sections (10 m thick) of the body, were cut using a
cryostat at ¡20°C and mounted on glass slides coated with
Vectabond (Vector Laboratories, Burlingame, USA). Sec-
tions were Wxed in 4% formaldehyde in Tris-buVered saline
(TBS; 50 mM Tris and 150 mM NaCl, pH 7.5) for 10 min
and subsequently washed in TBS with 0.05% Tween-20
(TBST) (Sigma-Aldrich, Zwijndrecht, The Netherlands).
Subsequently, sections were incubated for 10 min with
10% normal swine serum (Vector laboratories) in TBST
after which sections were incubated for 24 h at 4°C with
anti-phospho Akt polyclonal antibody (Santa-Cruz Bio-
technology, USA) diluted 1:50 in TBST. After incubation
with primary antibody, the slides were washed in TBST
and subsequently placed in 0.25% (v/v) acetic anhydride in
0.1 M triethanolamine buVer (pH 8) for 10 min followed by
rinsing in TBST. After this, sections were incubated for
60 min at 20°C with secondary anti-rabbit immunoglobulin
G (IgG) antibody covalently coupled to alkaline phospha-
tase (Vector Laboaratories) diluted 1:100 and washed in
TBST. After this, sections were incubated for 5 min with
alkaline phosphatase (AP) buVer (0.1 M NaCl, 0.1 M Tris,
50 mM MgCl2 and 0.1% Tween-20, pH 9.5) followed by
incubation with BM Purple AP substrate (Roche Applied
Sciences, Almere, The Netherlands) for 30, 45 or 60 min
which was followed by rinsing in TBST. All sections were
mounted in glycerine-gelatin and stored at 4°C in the dark
until staining intensity was measured. The absorbance val-
ues of the BM Purple in the sections were determined using
a Leica DMRB microscope (Wetzlar, Germany) Wtted with
calibrated gray Wlters using diVerent interference Wlters.
Absorbances for BM Purple were determined at 550 nm.
Images were recorded with a £20 objective and a Sony
XC-77CE camera (Towada, Japan) connected to a LG-3
frame grabber (Scion; Frederick, MD) in an Apple Power
Macintosh computer. Recorded images were analysed with
the public domain program NIH-Image V1.61 (US National
Institutes of Health, available at http://rsb.info.nih.gov/nih-
image/). Gray values were converted to absorbance values
per pixel using the gray Wlters and a third-degree polyno-
mial Wt in the calibrate option of NIH-image programme.
Morphometry was calibrated using a slide micrometer and
the set scale option in NIH-image, taking the pixel-aspect
ration into account. An independent t test was used to test
for diVerences in phospho-Akt levels in cardiac myocytes
of normoxic and hypoxic Wsh. A P value of less than 0.05
was considered signiWcant. Values are means § S.E.M.
RNA preparation and biological sampling
After dissection hearts were homogenized in a Dounce
homogenizer using 1 ml Trizol solution (GibcoBrl, Life
technologies). The whole heart was used and for each bio-
logical sample hearts were pooled from Wve diVerent ani-
mals. After Trizol extraction, total RNA was further
puriWed using RNAeasy columns (Qiagen). RNA samples
were analyzed for quality control by Lab-on-a-chip analysis80 J Comp Physiol B (2008) 178:77–92
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(Agilent) and on agarose gels. For the array experiment Wve
arrays were done for normoxic and 5 arrays for the hypoxic
condition. Biological samples (BS) came from two inde-
pendent experiments and one technical replicate (TR) was
included (2BS + 2BS + TR for normoxia and 2BS + 2BS
+ TR for hypoxia). As mentioned above for each BS, hearts
from Wve diVerent animals were pooled.
Microarray analysis
The AVymetrix GeneChip® ZebraWsh Genome Arrays con-
taining 15,509 Danio rerio gene transcripts were used.
Probe sets on the arrays were designed with 16 oligonu-
cleotide pairs to detect each transcript and procedures were
in full support of MIAME standards. Labeling and micro-
array hybridization were performed by ServiceXS (Leiden,
The Netherlands), including prior a standard round of RNA
ampliWcation according to standard AVymetrix protocols.
The criteria used for diVerential expression were greater or
equal than 2-fold induced or reduced and P · 0.02. Data
analysis was done using Rosetta Resolver. All expression
data was submitted to the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo). The series entry num-
ber is GSE4989 and the following 10 accession numbers
were assigned: GSM112796 and GSM112798-GSM112806.
A complete list of diVerential regulated genes is shown in
Supplemental Table 1.
Gene ontology analysis
The Gene ontology analysis was performed using eGOn
and the database of the Norwegian Microarray Consortium
(http://www.genetools.microarray.ntnu.no/egon/) and the
most recent updated Unigene numbers for zebraWsh (May
2007). 13414 Unigene numbers were annotated to the
AVymetrix gene chip used. eGOn Enrichment analysis was
used for the entire AVymetrix set versus the identiWed 376
gene set based on the new Unigene numbers. A master tar-
get test was performed (using Fishers exact test) and the cut
oV for positives was set to P<0.05. The available three
categories, molecular function, biological process and cel-
lular component were all tested and are shown in this data-
set (Supplemental Data 1). The fold enrichment was based
on the percentage found within the diVerentially expressed
genes divided by the percentage on the total chip. A list of
all Unigene numbers found in the diVerent categories is
given in Supplemental Data 2.
Real-time quantitative RT-PCR
For veriWcation of gene expression data, we used quantita-
tive real-time RT-PCR. Biological RNA samples were
obtained from a third independent experiment and as men-
tioned above for the microarrays, for each BS hearts from
Wve diVerent animals were pooled. The Roche Master
SYBR Green kit was used for the RT-PCR reactions. The
annealing and synthesis temperature was 55°C alternating
with 96°C for 45 cycles. Dissociation protocols were used
to measure melting curves and control for unspeciWc sig-
nals from the primers. A measure of 100 ng of total RNA
was used per reaction. A standard curve for -actin using 1,
5, 10, 100 and 500 ng of total RNA was used for normaliza-
tion. Samples were measured in the Roche LightCycler.
The primer3 software (http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3_www.cgi) was used to design primers for
short amplicons between 50 and 100 bases. The primers
used are shown in Supplemental Table 2.
Results
We describe here the survival rates of adult zebraWsh upon
immediate and gradual exposure to diVerent pO2 concentra-
tions. Immediate exposure to pO2 of 15 Torr (O2 concentra-
tion of 0.8 mg/l or 10% air saturated water) was lethal for
the adult zebraWsh and none survived for longer than 72 h
(Fig. 1). If lowered gradually (see experimental procedures
for regimen in Sect. “Hypoxia treatment”) zebraWsh were
able to grow and gain weight at O2 levels of 10% air satura-
tion. The zebraWsh were able to survive for longer than
6 months and no mortality was observed, demonstrating
Table 1 Statistical analysis of histological sections (5 m) from
zebraWsh (Danio rerio) and cichlid (Haplochromis piceatus) hearts
Midline sections of zebraWsh and cichlids raised under normoxic and
hypoxic conditions were chosen and subdivided in smaller areas. In the
case of D. rerio, each subarea of the section was 900 m2 whereas in
the case of the H. piceatus it was 10,000 m2. Then, subareas were
randomly picked and the amount of cardiac myocyte nuclei were
counted. The vast majority of cardiac myocytes were mononucleated
cells. Hundred subareas per section were counted per specimen. Three
sections per heart were visually analyzed (with a magniWcation of
20£). In total 6 diVerent zebraWsh hearts (from three independent
experiments) were investigated for hypoxic conditions and 6 for norm-
oxic condition. In total 1,800 subareas were quantiWed per heart and
condition used. The same was done for the cichlids (for which bigger
subareas were counted). A two-tailed t test was applied and a signiW-
cant diVerence (P < 0.001) in the amount of nuclei present in the hearts
of normoxia versus hypoxia groups was observed for both species
Number of cardiomyocyte nuclei per section
ZebraWsh 
(nuclei per 900 m2)
Cichlid 
(nuclei per 10,000 m2)
Normoxia Hypoxia Normoxia Hypoxia
Mean 9.81 13.67 14.7 24
SD 0.30 0.39 0.50 0.68
P value 9.9 £ 10¡17 7.6 £ 10¡12J Comp Physiol B (2008) 178:77–92 81
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that they can well adapt to these conditions (data not
shown). For the experiments with zebraWsh and cichlids,
the pO2 concentration was gradually lowered to 10% air
saturation (0.8 mg/l) (see “Material and methods”) and
Wshes were kept under 10% air saturation for 3 weeks. Con-
trol groups were always kept in parallel under normoxic
conditions.
Phenotypic changes in the heart of adult teleosts 
under chronic constant hypoxia (CCH)
In comparison to the normoxic control groups, we observed
a signiWcantly smaller ventricular outXow tract and reduced
lacunae within the central ventricular cavity and reduced
lacunae around the trabeculae in midline sections of hearts
of both zebraWsh (Danio rerio) (Fig. 2a) and cichlids (Hap-
lochromis piceatus) (Fig. 2b) exposed to CCH. In addition
to the midline sections, none of the sections investigated
from hypoxia treated Wshes showed a ventricular outXow
tract in comparable size to the normoxic controls (data not
shown). In addition to the midline sections, none of the lat-
eral sections (to both sides of the midline) investigated from
hypoxia treated Wshes showed a ventricular outXow tract as
well as lacunae in a comparable size to the normoxic con-
trols (data not shown). The larger cichlid hearts were also
perfused and midline sectioned and showed similar results
with a smaller ventricular outXow tract and reduced lacunae
(Fig. 2b-H). This might represent ventricular hypertrophy or
hyperplasia in both walls and trabeculae, which could lead
to the observed cavity obliteration in these sections. We
quantiWed the number of cardiac myocyte nuclei per area in
the midline sections of both zebraWsh and cichlids under
normoxic, as well as hypoxic conditions. A signiWcant
diVerence in both species was observed and showed that
hypoxia led to a 1.4- and 1.6-fold increase in the number of
cardiac myocyte nuclei per area in zebraWsh and cichlid
hearts, respectively (Table 1). Cardiac myocyte nuclei in
sections were clearly distinguishable from nuclei of other
cells like erythrocytes and Wbroblasts and only centralized
nuclei in cardiac myocytes (which are more elongated than
nuclei from erythrocytes) were counted. Furthermore, scan-
ning electron microscopy (SEM) was used to conWrm these
Wndings in the smaller zebraWsh hearts (Fig. 3). Future
research is warranted in order to assess further how the car-
diac myocytes adapt to CCH in the Wsh heart.
Gene expression changes in the heart of adult zebraWsh 
under chronic constant hypoxia (CCH)
In this study, we used microarrays for the transcriptional
proWling of up and downregulated genes in response to
hypoxia in the zebraWsh heart. We identiWed 376 genes that
were diVerentially expressed under hypoxic conditions, out
of which 116 genes showed a decrease in gene expression
(30.9%) in comparison to 260 genes which showed
increased expression levels (69.1%).
All 376 diVerentially expressed genes, including the
ones with oligo sequences which could not be annotated so
far (referred therein either as transcribed locus or zebraWsh
clone) are shown in the complete Wle (Supplemental Table 1).
Functional groups are color coded and if possible, gene
functions are brieXy summarized and OMIM links given.
Functional groups of diVerentially expressed 
genes in the heart
We have clustered the diVerential expressed genes accord-
ing to known functions (Table 2). Genes can have more
than one particular function assigned, so some genes can
appear in more than one group. In addition, a gene ontology
analysis was performed using eGOn to determine gene
enrichment and overrepresentation in the three categories
of molecular function, biological processes and cellular
components (Supplemental Data 1 and 2).
Proteinbiosynthesis (Translation): In the group linked to
proteinbiosynthesis, only three genes showed decreased
expression under hypoxic conditions. All three were found
to be part of the mitochondrial translational machinery. In
contrast, 9 non mitochondrial genes linked to proteinbio-
synthesis showed all increased expression (Table 2).
Metabolism: The group with metabolic genes contains
11 repressed and 28 genes with enhanced expression
(Table 2). The repression majorly involves metabolic genes
linked to -oxidation and lipid metabolism. Among the
Fig. 1 Survival of zebraWsh embryos after immediate exposure to
hypoxia. ZebraWsh were immediately exposed to hypoxia (15 Torr;
0.8 mg/ml; 10% air saturated water). Results are derived from three
independent experiments with n = 30 in each experiment (adding to a
total of 90 Wsh tested). After 24, 48 and 72 h, dead and alive Wsh were
counted. Shown here is the percentage of dead Wsh at the respective
time points and the standard deviation. At 24 h 53.3%(§4.4) of Wsh
were dead, at 48 hours 85.3% (§5.1) and at 72 hours 100% (§0).
Control groups (n = 30), which were in parallel exposed to normoxic
conditions showed no mortality (not shown). None of the zebraWsh
survived the immediate exposure to an O2 concentration of 0.8 mg/l
(10% air saturation) over the 3-day period. In contrast, Wshes gradually
exposed to hypoxia showed no induced mortality for even the 25 day
time periods used in our experiments82 J Comp Physiol B (2008) 178:77–92
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Fig. 2 Histological changes of 
zebraWsh and cichlid hearts after 
exposure to chronic constant 
hypoxia. a shows zebraWsh 
hearts that were dissected, 
sectioned and stained with a 
hematoxylin–eosin staining with 
A, B and E representing 
normoxic and C, D and 
F hypoxic conditions. Cell 
nuclei are seen in dark 
(dark blue in online version) and 
cell cytoplasm in light (pink in 
online version). Pictures A, C, E 
and F have the same 
magniWcation (10£). Images B 
and D represent a 20£ magniW-
cation of cardiac muscle (D). 
Abbreviations used are: a atri-
um; v ventricle; vo ventricular 
outXow tract and ca conus arteri-
osus. b (A–F) corresponds to 
sections of cichlid hearts, which 
were treated the same way as the 
ones above from zebraWsh and G 
and H show cichlid hearts which 
have been perfused prior to 
dissection and were stained with 
either hematoxylin–eosin (A–F) 
or Azan blue (G, H). In A, B, C 
and G pictures of normoxic 
conditions are shown and D, E, 
F and H represent the 
corresponding hypoxic 
conditions. Similar results for 
both the zebraWsh and the cichlid 
hearts were observed in three 
independent experimentsJ Comp Physiol B (2008) 178:77–92 83
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metabolic genes with enhanced expression, are pyruvate
kinase and aldolase which both are key enzymes for glycol-
ysis indicating a shift from aerobic to anaerobic metabolism
induced by hypoxia.
Protection against reactive oxygen species (ROS): The
group of genes important for protection against ROS con-
tains 6 genes which are all enhanced under hypoxia.
Apoptosis: We found four genes linked to programmed
cell death to be enhanced by hypoxia. Two of these, the
death receptor 5 (DR5) and the BNIP3 homologue, are con-
sidered to be pro-apoptotic, whereas apoptosis inhibitor 5
and Bax inhibitor have been shown to have anti-apoptotic
properties (Tewari et al. 1997; Xu and Reed 1998).
Growth regulation: In the group of genes linked to
growth regulation, we found 9 genes to be repressed and 8
genes with enhanced expression. Within the group of 8
repressed genes, we found 5 antiproliferative genes: spry4
and dual speciWcity phosphatase 5 both inhibit mitogen-
activated kinases (MAPK), SOCS3 binds and inhibits Janus
kinases (JAK) and thereby prevents STAT3 activation.
BTG2 which is important in the G1/S transition and TIEG2
is a transcriptional repressor with antiproliferative func-
tions. Although some genes involved in cell proliferation,
like the transcription factor c-fos were repressed by
hypoxia (see also “Discussion”), the regulation of the vast
majority (13 of 17) of identiWed genes in this group sug-
gests stimulation of proliferation (Table 2).
InXammation: 14 genes involved in the inXammatory
response were identiWed to be diVerentially regulated and
all showed increased expression upon hypoxia treatment.
Heart-related function: Several genes linked to cardiac
hypertrophy, cardiomyopathy (disease of the heart muscle)
and cardiac infarction were identiWed in this study (see
Table 2 and “Discussion”).
Muscle-related function: Several sarcomeric genes
linked to hypertrophy showed decreased expression under
hypoxic conditions (Table 2 and “Discussion”).
Development: The genes in this group were all found to
be upregulated by hypoxia among them the gene for notch-
2 and notch-3. Notch receptors are transmembrane recep-
tors with essential roles in development including heart
development.
Transport (cellular and vascular): A heterologous group
containing the gene for embryonic hemoglobin beta e2,
important for oxygen transport and hemopexin which is
important for heme and iron transport and was found to be
upregulated.
Angiogenesis: It is well known that hypoxia via the
hypoxia inducible factor 1 (HIF1) pathway leads to
angiogenesis. In the zebraWsh heart under CCH, we
observed increased expression of HIF1 as well as Wbrino-
gen- and -. Fibrinogen- has been shown to stimulate
HIF1 and VEGF expression and thereby induces angio-
genesis (Shiose et al. 2004).
Expression changes of known hypoxia responsive genes
Examples for regulation of known hypoxia responsive
genes are HIF1, insulin growth factor-2 (IGF-2), insulin
growth factor binding protein 1 (IGFbp1) and caveolin 3.
The transcription factor Hif1 is pivotal in the cellular
response to hypoxic stress (Semenza 1999). We further
observed increased expression of the egl nine homolog, a
gene which was shown to be induced by hypoxia through
Fig. 3 Morphological changes 
of zebraWsh and cichlid hearts 
after exposure to chronic 
constant hypoxia. Scanning 
electron microscopy pictures of 
hearts from normoxia control 
zebraWsh (a, c and d) and 
hypoxia-treated zebraWsh 
(b, e and f). The bigger images 
show half of a heart ventricle, 
sectioned longitudinally. The 
smaller images represent a 
higher magniWcation of cardiac 
muscle. The scale is given at the 
bottom of each picture. 
Abbreviations used are: 
v ventricle and vo ventricular 
outXow tract84 J Comp Physiol B (2008) 178:77–92
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Table 2 Functional groups 
of diVerentially expressed genes
UniGene GeneBank Fold Gene name
Upregulated genes
Angiogenesis
Dr.11575 NM_173244 2.3 T-cell acute lymphocytic leukemia 1; TAL1
Dr.845 BG729013 2.8 Fibrinogen alpha/alpha-E chain 
Dr.4907 BC045868 4.2 Fibrinogen, gamma polypeptide
Apoptosis
Dr.15862 AF493987 2.1 BCL2adenovirus E1b 19 interacting protein3
DrAVx.1.39 AF302789 2.3 Death receptor
Dr.20106 AI722277 2.8 Apoptosis inhibitor 5
Dr.4039 BQ480688 21.8 BAX inhibitor 1
Cell adhesion
Dr.6007 NM_131820 2.9 Cadherin 1
Dr.25140 BQ262802 3.3 Tumor-associated calcium signal transducer 
Dr.4409 BC049036 4.4 CD9 antigen
Dr.25140 BQ262802 7.7 Tumor-associated calcium signal transducer glycoprotein
Development
Dr.11575 NM_1732 2.3 T-cell acute lymphocyte leukemia 1 (tal 1)
Dr.23348 BE201653 2.6 Bone morphogenetic protein 3b; (bmp 3)
Dr25405 BC013923 2.8 SOX2 SRY-box 2
Dr.6382 AW165053 2.9 Hedgehog-interacting protein
Dr.10879 U97669 3.0 NOTCH3 Notch homolog 3 (Drosophila)
Dr.15055 BC050172 3.6 Chemokine receptor 4a
Dr.6787 BI533426 5.5 Noelin
Dr.16720 BI980847 6.3 notch 2
Disease related
Dr.6349 AW116668 2.4 Eparin cofactor II
Dr.21064 BC046075 4.5 4hydroxyphenylpyruvate dioxygenase HPD
Dr.12584 NM_131211 5.4 Gata binding protein 3 (GATA3)
Dr.3530 AI497545 79.3 Prion protein (prp) gene
Growth regulation
Dr.8145 NM_13143 2.2 Insulin like growth factor 2 (IGF-2)
Dr.7609 BI475857 2.4 Prolactin receptor
Dr.8285 NM_13136 2.4 Mad homolog 2 
Dr.8947 CD594735 2.5 Spint 2
Dr.822 BM184127 2.5 Spint 2
Dr.3563 CD014488 2.8 Tetraspan membrane protein IL-TMP
Dr.8587 NM_17328 2.9 Insulin-like growth factor binding protein 1 
Dr.2596 BM342901 3.2 Cyclin I
Dr.8587 AL910822 3.4 Insulin-like growth factor binding protein 1
Dr.26458 BC053206 5.6 m-ras
Heart related
Dr.15088 BM181749 4.3 Lectin galactoside-binding soluble 1; (galectin10-like 3)
Dr.4867 AI496840 5.5 Haptoglobin
Dr.3585 AY049731 6.6 Angiotensinogen 
Dr.2452 BQ284848 4.3 Complement component C9 
Dr.18453 BC044525 4.8 Uridine phosphorylase
Dr.3025 BG738204 2.7 Alpha-2 macro-globulin; A2MG
InXammation
Dr.12491 BI672168 2.1 Complement C4–2J Comp Physiol B (2008) 178:77–92 85
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Table 2 continued UniGene GeneBank Fold Gene name
Dr.4047 NM_131627 2.3 Small inducible cytokine A (scyba)
Dr.5053 NM_131723 2.3 Kruppel-like factor 4 
Dr25207 X06465 2.5 Complement component 8, gamma polypeptide
Dr.6845 K02765 2.9 C3 complement component 3
Dr.5741 BU710482 3.2 Complement component b fb
Dr.7722 BI878414 3.5 Complement C3-H1
Dr.22244 AW019781 3.6 Complement C1s
Dr.22133 AW076768 3.7 c1rs-A and clrs-B
Dr.5528 AI497212 4.2 Complement component C9
Dr.2452 BQ284848 4.3 Complement component C9 
Dr.1730 AI721528 4.8 cfI-B complement control protein factor I-B 
Dr.2452 BM778002 5.8 Complement component C9
Dr.20291 BM036389 6.5 Complement C3-S
Dr.190 NM_131338 7.9 Complement component factor B 
Dr.1192 AB071601 2. Lipocalin-type prostaglandin D synthase-like protein
Metabolism
Dr.9492 BI882244 2.0 SulWde dehydrogenase like
Dr.15574 BM571467 2.1 Hypoxanthine _hosphor-ribosyltransferase 1
Dr.3332 AI943053 2.2 Angiopoietin 5 
Dr.16130 CD014898 2.3 Alcohol dehydrogenase 8 b
Dr.3959 BI43001 2.5 5-nucleotidase
Dr.22205 AW019477 2.6 Oxidoreductase
Dr.1699 AI667249 2.7 Pyruvate kinase
Dr.5504 BI879550 3.2 Cystathionine-beta-synthase
Dr.1202 AJ245491 3.9 Apolipoprotein A-I
Dr.4111 BC053267 4.2 Fructose-1,6-bisphosphatase 1
Dr.18834 AW019321 4.2 Urate oxidase
Dr.19224 BC050167 4.3 Aldolase b
Dr.4938 NM_131645 4.4 Fatty acid desaturase 2
Dr.12654 BC046901 14.8 ELOVL family member 6,
Dr.5488 AI545593 17.3 Apolipoprotein A-IV 
Muscle related
Dr.3585 AY049731 6.6 Angiotensinogen
Dr.2452 BQ284848 4.3 Complement component C9
Proteolysis
Dr.20934 AF541952 2.6 Trypsin precursor
Dr.3025 BG738204 2.7 Alpha-2-macroglobulin 
Dr.22139 AW018965 3.0 Alpha-1-antitrypsin
Dr.25331 AI658072 4.1 Alpha-2-macroglobulin-2
Dr.12602 NM_139180 4.3 Lysozyme
Dr.1605 BM185388 4.4 Protease inhibitor 1
Dr.17459 CD586837 4.8 Inter-alpha-trypsin inhibitor heavy chain H3 
Dr.3073 AI585030 5.0 Serine protease inhibitor alpha 1
Dr.26371 AI667676 5.4 Prostasin
Dr.3025 BM530427 5.6 Alpha-2-macroglobulin-1
Dr.3025 BM316867 6.5 Alpha-2-macroglobulin-2
Dr.2960 X67055 3.5 ITIH3 pre-alpha (globulin) inhibitor, H3 polypeptide
Dr.25379 BI326783 6.7 Alpha-2-macroglobulin
Dr.4797 AI959534 7.8 26–29 kD-Proteinase protein86 J Comp Physiol B (2008) 178:77–92
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Table 2 continued UniGene GeneBank Fold Gene name
ROS protection
Dr.20068 NM_131075 2.1 Metallothionein (mt)
Dr.5399 AI957765 2.3 Biliverdin I Beta Reductase
Dr.14058 CD015351 3.5 Glutathione S-transferase theta 1
Dr.25160 BC049475 5.9 Metallothionein 2
Dr.3613 BC048037 6.0 Cerulopasmin
Dr.4905.1 BC045464 6.5 Uncoupling protein 4
Signal transduction
Dr.9852 AW826425 2.1 CAM kinase 1
Dr.8591 BM186508 2.9 Rho guanine nucleotide exchange factor 10
Dr.6236 AW115973 3.1 Rho guanine nucleotide exchange factor 5
Dr.1267 BC051157 3.4 Phospholipase C delta
Dr.22129 BC016668 3.9 RRAGC Rag C (Ras-related GTP binding C)
Dr.7255 AW116479 4.4 Protein phosphatase 1,
Dr.4453 BC044421 5.8 Phosphoprotein phosphatase
Translation
Dr.13234 BM036471 2.0 Ribonuclease P 
Dr.382 CB363830 2.1 Nucleolin
Dr.6949 AW078116 2.1 RNA 3-terminal phosphate cyclase-like protein (HSPC338)
Dr.13563 BI890729 2.3 Methionyl aminopeptidase 2
Dr.26328 AL723696 2.3 Eukaryotic translation initiation factor 4A,
Dr.17693 BQ078285 3.7 40 S ribosomal protein S6
Dr.20270 BI674050 5.9 Ribosomal protein L12 
Dr.25224 CD015330 20.4 Ribosomal protein L12 
Dr.12439 BM533848 17.5 Heterogeneous nuclear ribonucleoprotein K 
Dr.12439 BM533848 24.2 Heterogeneous nuclear ribonucleoprotein K
Dr.14821 BM071714 33.8 Heterogeneous nuclear ribonucleoprotein K 
Dr.12502 BQ284686 40.7 Heterogeneous nuclear ribonucleoprotein K 
Dr.12439.  BM534432 40.9 Heterogeneous nuclear ribonucleoprotein K
Dr.12439 BQ616930 45.4 Heterogeneous nuclear ribonucleoprotein K
Transport
Dr.1084 BQ109772 3.0 Clathrin coat assembly protein AP19
Dr.5562 X04506 3.0 APOB apolipoprotein B (including Ag(x) antigen)
Dr.13231 BM778646 4.2 Solute carrier family 22
Dr.30444 AY329629 4.3 Embryonic globin beta e2
Dr.24250 AF489105 2.0 Uroporphyrinogen III synthase
Dr.10343 NM_131687 4.7 Na+K+ transporting, alpha 1a.2 polypeptide
Dr.7634 AW115757 11.3 Hemopexin
Downregulated genes
Angiogenesis
Dr.26411 BQ783571 ¡8.9 Fast muscle troponin I
Dr.15501 BM316040 ¡2.1 Similar to CYR6 HUMAN CYR61 protein precursor, 
Insulin-like growth factor-binding protein 10
Cell adhesion
Dr.251 BQ285646 ¡2.3 Cadherin 11
Disease related
Dr.22774 AW280206 ¡5.7 ras-like GTP-binding protein RAB27A
Dr.1816 AL720262 ¡4.4 Ataxin 2-binding protein
Dr.9893 BM036473 ¡2.3 FibrillarinJ Comp Physiol B (2008) 178:77–92 87
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Table 2 continued UniGene GeneBank Fold Gene name
Dr.16726 BI429372 ¡2.0 netrin G1
Growth regulation
Dr.12986 CA787334 ¡5.3 v-fos
Dr.12986 BI881979 ¡5.0 v-fos
Dr.12986 BM957279 ¡4.5 v-fos
Dr.1221 AW510198 ¡4.3 Pmx-1b (PHOX-1)
Dr.12986 BI881979 ¡4.2 v-fos
Dr.12410 NM_131826 ¡2.4 Sprouty homolog 4 
Dr.6431 BC049326 ¡2.3 Suppressors of cytokine signaling 3
Dr.6511 NM_130922 ¡2.2 B-cell translocation gene 2
Dr.5365 AI601685 ¡2.2 Dual speciWcity phosphatase 5
Dr.12062 BC047814 ¡2.1 Epidermal growth factor receptor kinase substrate EPS8
Dr.17286 BM777144 ¡2.0 Hormone-regulated proliferation-associated 
20 kDa protein
Dr.9448 BM156058 ¡2.0 TGF-beta-inducible early growth response protein 2
Heart related
Dr.20010 BQ826502 ¡7.0 ATPase, Ca++ transporting, cardiac muscle (ATP2A1)
Dr.1448 AL717344 ¡3.5 Fast skeletal myosin light chain 1a
Dr.20990 AY033829 AY081167 ¡2.4–2.1 Titin
Metabolism
Dr.24950 BC053305 ¡4.1 Creatine kinase CKM3
Dr.9528 BC045993 ¡3.5 Pyruvate dehydrogenase kinase
Dr.146 AI477401 ¡2.9 Carnitine O-palmitoyltransferase II
Dr.21501 AI667180 ¡2.4 Short-chain acyl-CoA dehydrogenase 
Dr.19643 AL918850 ¡2.4 FabG beta-ketoacyl -reductase
Dr.15059 BM530407 ¡2.2 Elongation of very long chain fatty acids (Cig30)
Dr.21040 BC045479 ¡2.1 Glucose-6-phosphatase, transport protein 1
Dr.988 AW154697 ¡2.1 Dodecenoyl-coenzyme A delta isomerase 
Dr.11971 BG727588 ¡2.0 Carnitine O-acetyl-transferase
Dr.4777 AW420997 ¡2.0 Succinate-CoA ligase
Dr.11252 BC047826 ¡2.0 Creatine kinase, mitochondrial 1 
Muscle related
Dr.21800 AI883923 ¡5.0 Myosin binding protein C
Dr.5066 AF524840 ¡3.4 Alpha-actinin 3
Dr.24260 NM_131619 ¡3.0 Myosin, light polypeptide 3
Dr.2914 BC045520 ¡2.5 Myosin light polypeptide 2; mylz2
Dr.20990 AY033829 AY081167 ¡2.4–2.1 Titin
Dr.1435 AI353817 ¡2.0 Caveolin 3
Dr.18657 BQ479700 ¡2.1 Carbonic anhydrase II
Dr.26411 BQ783571 ¡8.9 Troponin I
Proteolysis
Dr.3581 BM101561 ¡8.3 Chymotrypsinogen B1 
Dr.3581 BM101561 ¡7.5 Chymotrypsinogen B1
Signal transduction
Dr.22841 AI641080 ¡2.4 Serum deprivation response protein (SDPR)
Translation
Dr.7939 AW281840 ¡2.7 Mitochondrial elongation factor G1
Dr.1286 BM036808 ¡2.2 Mitochondrial ribosomal protein L48
Dr.18218 AL909921 ¡2.1 Mitochondrial 28 S ribosomal protein S12 88 J Comp Physiol B (2008) 178:77–92
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the Hif1 pathway (Pescador et al. 2005). IGF-2 gene- and
protein expression had been shown to be upregulated by
hypoxia (Beilharz et al. 1995). It was shown that IGFbp1
also is a hypoxia-inducible gene in zebraWsh embryos and it
mediates hypoxia-induced embryonic growth-inhibition
and developmental-retardation (Kajimura et al. 2005a).
Both IGF-2 and IGFbp1 were found upregulated in our
study. We observed decreased expression of caveolin 3 in
the hearts of zebraWsh exposed to CCH, earlier Wndings
showed that chronic myocardial hypoxia led to decreased
caveolin-3 protein expression in rabbit hearts (Shi et al.
2000). These Wndings indicate that the hypoxic conditions
used lead to hypoxic stress in the Wsh heart.
Evaluation of microarray results by quantitative 
real-time RT-PCR
To further verify our results, we used quantitative real-time
PCR for 10 of the transcripts. We conWrmed the gene
expression changes found in the microarray studies for
these 5 up- and 5 downregulated transcripts by this inde-
pendent method (Fig. 4). The downregulated zebraWsh
genes tested were: c-fos, phox1, creatine kinase (ckm3),
nebulin, titin, and the upregulated genes tested were: metal-
lothionein, pyruvate kinase, apoptosis inhibitor 5, igfbp1
and notch-2. The fold induction values were not always
directly comparable to the array data but in all cases induc-
tion or reduction was conWrmed. Quantitative diVerences
between array data and qPCR results have been reported
before (Meijer et al. 2005; Ton et al. 2003; van der Meer
et al. 2005).
Assessment of microarray results for the IGF/PI3K/Akt 
pathway by comparing phospho-Akt levels in cardiac 
myocytes of normoxic versus hypoxic zebraWsh hearts
The IGF/PI3K/Akt pathway is activated by IGFs, which are
antagonized by the IGFbp1. To test the eVects of the upreg-
ulation of both IGF-2 and IGFbp1, we assayed phospo-Akt
levels in cardiac myocytes and showed that phospho-Akt
levels were not diVerent between normoxic and hypoxic
cells. Figure 5 shows cytoplasmic immunohistochemical
staining of phospho-Akt. The antibody recognizes phos-
phorylated and detects the phospho-Akt1/2/3 forms. The
incubation times for the primary and secondary antibody as
well as the BM Purple were optimized to obtain a good sig-
nal to noise ratio. Absorbances were linearly related to the
time of incubation with the primary and secondary antibod-
ies as well as that of BM Purple. Figure 5d shows for norm-
oxic Wsh the absorbance values of the phospho-Akt staining
in cardiac myocytes as well as skeletal muscle Wbers from
the tail as a function of the incubation time with BM Purple
AP substrate. The absorbance values for the heart are con-
siderably higher than for the skeletal muscle Wbers. How-
ever, for both cardiac and skeletal muscle the absorbances
are linearly related with the incubation time with BM Pur-
ple AP substrate and increase at the same relative rate. This
implicates that the absorbance of BM Purple after 45 min
incubation with BM Purple AP substrate did not reach satu-
ration and therefore provides a semi-quantitative estimate
Table 2 continued UniGene GeneBank Fold Gene name
Transport
Dr.676 BC050956 ¡4.4 ADT2, ADP,ATP carrier protein
Dr.25199 CD014403 ¡2.1 Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) 
Dr.2784 AI942949 ¡2.0 Solute carrier family 25 
Dr.11127 BG306498 ¡3.7 Synaptotagmin I
Dr.11127 AW826278 ¡3.2 Synaptotagmin I 
Dr.13273 BI885460 ¡2.3 GTP-binding protein rab15 
Dr.22748 AW280026 ¡2.7 trpn1
Dr.11302 BG306530 ¡2.1 ATPase (Ca++ transporting plasma membrane 2)
Fig. 4 VeriWcation of gene expression changes by quantitative real-
time PCR. 10. selected genes, which were found to be diVerentially ex-
pressed on the microarrays, were further analyzed by quantitative real-
time RT-PCR. Relative expression is given based on normalization to
-actin. A standard curve for -actin was included in each experiment
and data represents three independent experiments each done in tripli-
cates. The primers used are given in Supplemental Table 2J Comp Physiol B (2008) 178:77–92 89
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of the phospho-Akt content in the cardiac myocytes. Absor-
bances of staining for phospho-Akt in normoxic and hyp-
oxic cardiac myocytes were not shown to be signiWcantly
diVerent (Fig. 5E, P < 0.48), which indicates that hypoxia
did not change the activation of the Akt pathway in the
cardiac myocytes.
Discussion
In the aquatic environment, oxygen concentrations can
often vary, and being able to adapt to changes in oxygen
levels can be advantageous for the survival of aquatic ani-
mals. This might be in part the reason why some teleosts
have developed the ability to withstand extreme hypoxic
conditions.
In this study, we have focused on the long-term response
to hypoxia in the Wsh heart. The hypothesis is that the
zebraWsh heart, in contrast to most mammalian hearts,
which are characterized by relative intolerance to injury or
the lack of oxygen, are able to adapt to extreme hypoxic
conditions.
We showed that chronic hypoxia of zebraWsh caused a
smaller ventricular outXow tract, reduced lacunae and
increased cardiac myocyte densities in the heart. These
Wndings suggest that hypoxia induced an increase of the
cardiac myocyte volume or at least did not result in a loss of
cardiac myocytes. This is in contrast to mammals where
tissue hypoxia in chronic heart failure leads to apoptosis
and considerable losses of cardiac myocytes (see for
review, Sabbah et al. 2000a). In mammals, compensation
for this loss of cardiac myocytes occurs mainly by hypertro-
phy of the remaining cardiac myocytes (Ostadal and Kolar
2007), although regeneration of myocardium by prolifera-
tion of cardiac myocytes may occur also but to a limited
extend (Beltrami et al. 2001). Our assay for phosho-Akt did
not show any enhancement of Akt activity in response to
the CCH, suggesting a lack of hypertrophic signaling via
the phosphotadilinositol 3 kinase pathway. However, the
density of cardiac myocyte nuclei increased by 50% during
CCH, which indicates substantial proliferation of cardiac
myocytes and/or nuclear hyperplasia. Recently, it has been
shown that the zebraWsh heart has the ability to regenerate
from mechanical cardiac injury by proliferation of cardiac
myocytes (Poss et al. 2002). If the zebraWsh heart responds
to chronic hypoxia in a similar way as to mechanical dissec-
tion, this will be beneWcial in preventing apoptosis of car-
diac myocytes as the diVusion distance for oxygen are not
increased as during hypertrophy, which will help to prevent
the development of anoxic cores in the cardiac myocytes
(Des Tombe et al. 2002; van der Laarse et al. 2005). In the
case that the increase in cardiac myocyte nuclear density
during chronic hypoxia was due to nuclear hyperplasia and
nuclear ploidy, the observed smaller ventricular outXow
tract and reduced lacunae may have been the result of
hypertrophy of the existing cardiac myocytes. The histolog-
ical assay in this study does not clearly distinguish between
hyperplasia and hypertrophy of cardiac myocytes. Future
Fig. 5 EVects of chronic constant hypoxia of the activation of Akt in
zebraWsh cardiac myocytes. Immunohistochemical staining of
phospho-Akt in cardiac myocytes of zebraWsh raised under hypoxic
a or normoxic b conditions. SpeciWcity is shown by the control
sections obtained from normoxic Wsh which were not incubated with
primary antibody against phospho-Akt c. For both cardiac myocytes
and skeletal muscle Wbers, the absorbance of the BM Purple is linearly
increasing at the same relative rate with the incubation time with BM
Purple AP substrate at the same relative rate d. Mean absorbances of
phospho-Akt staining (+S.E.M.) from normoxic and hypoxic cardiac
myocytes was not diVerent e)90 J Comp Physiol B (2008) 178:77–92
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investigation of the mechanisms underlying the general
morphological adaptations of teleost Wsh heart in response
to CCH requires a nuclear stain in combination with a clear
membrane stain, which allows determination of cell sizes in
addition to counts of cardiac myocyte nuclei.
We were interested in the underlying gene expression
changes of these adaptations. We found gene regulations in
a transcriptional network of the serum response element
(SRE), which are opposed to the ones described in mam-
mals. In the zebraWsh heart hypoxia repressed c-fos and
phox1 expression. Both genes are important in the same
transcriptional network, phox1 can transduce serum-
responsive transcriptional activity to the c-fos (SRE) by
interacting with serum response factor (SRF) (Simon et al.
1997). In mammals many studies showed increased expres-
sion of c-fos by hypoxia, e.g. in rats hypoxia induces c-fos
expression in the LV and RV (Deindl et al. 2003) and the
same held true in tissue culture cells (Webster et al. 1993).
Interestingly, repression of c-fos by hypoxia has also been
shown for the short-term response to anoxia in anoxia toler-
ant turtles (Greenway and Storey 2000). Is it possible that
repression of c-fos and phox-1 are important adaptations in
hypoxia tolerant animals?
Several novel gene expression changes induced by CCH
have been identiWed in this study (Table 2 and Supplemen-
tal Table 1). An example is the two Notch receptors, notch-
2 and notch-3, whose expression were induced by CCH.
Notch receptors have been shown to be important for heart
patterning and diVerentiation (Armstrong and BischoV
2004), cell fate determination and self renewal of stem cells
(Androutsellis-Theotokis et al. 2006; Silvia Bianchi 2006)
but so far have not been linked to the hypoxic response.
Several genes with links to human heart pathology were
found to be upregulated in this study. Among these were
two markers for myocardial infarction, complement com-
ponent C9 and haptoglobin. C9 is used as a marker for
myocardial infarction (Doran et al. 1996) and a polymor-
phism for haptoglobin predicts 30-day mortality and heart
failure in patients with diabetes and acute myocardial
infarction (Levy et al. 2002). We also observed increased
expression of fetuin-, a circulating calcium-regulatory gly-
coprotein that inhibits vascular calciWcation. Low fetuin-
levels have been associated with heart failure in mice
(Merx et al. 2005). Upregulation of fetuin- in the zebraWsh
heart could help to better tolerate CCH. Selenoprotein P
(SEPP1) is a heparin-binding protein that appears to be
associated with endothelial cells and has been implicated as
an oxidant defense in the extracellular space. Human popu-
lations that are selenium deWcient are susceptible to the
development of Keshan disease, a potentially fatal form of
cardiomyopathy (Nezelof et al. 2002). SEPP1 expression
was found to be increased in our study indicating a poten-
tial protective mechanism against oxidative stress in the
heart. This was further supported by the increased expres-
sion observed for several genes important for the protection
against reactive oxygen species (ROS) (Table 2). Among
them were metallothionein and glutathione S-transferase,
which are both known ROS scavengers. Metallothionein
has further been described to be protective against hypoxia-
induced apoptosis when overexpressed (Wang et al. 2001).
Our Wndings suggest ROS protection as an important adap-
tation to CCH in the Wsh heart.
Furthermore, our data show for the Wrst time that CCH
simultaneously induced upregulation of IGF-2 and the insu-
lin-like growth factor binding protein 1 (IGFbp1). In iso-
lated cardiomyoblasts, angiotensin II stimulates IGF-2
expression which is involved in the induction of apoptotic
signaling in rat hearts (Lee et al. 2006). We have observed
here both angiotensin and IGF-2 upregulation (Table 2).
The upregulation of IGFbp1 seems to be a general response
to hypoxia in zebraWsh embryos, where it mediates
hypoxia-induced embryonic growth retardation and devel-
opmental delay (Kajimura et al. 2005b). IGFbp1 is a
secreted protein, which binds to IGFs in the extracellular
environment and prevents receptor activation (Florini et al.
1996; Stewart and Rotwein 1996). Here, IGFbp1 by bind-
ing IGF-2, may have prevented both cardioprotective as
well as apoptotic eVects of enhanced IGF-2 expression. To
test the eVects of the upregulation of both IGF-2 and
IGFbp1, we assayed phospo-Akt levels in cardiac myocytes
and showed that phospho-Akt levels were not diVerent
between normoxic and hypoxic cells. This suggests that
either hypoxia-induced changes in mRNA expression did
not occur at the protein level or the eVects of increased
IGF-2 expression on the IGF-1 receptor (which can be acti-
vated by IGF-2) were blunted by the upregulation of the
IGFbp1. The fact that we did not observe increased phos-
pho-Akt levels suggests a lack of hypertrophic signaling as
enhanced phospho-Akt is required for cardiac hypertrophy
(DeBosch et al. 2006). This may be beneWcial for the heart
as hypertrophy of cardiac myocytes implicates an increase
in the diVusion distance for oxygen which may cause the
development of anoxic cores (Des Tombe et al. 2002),
release of cytochrome c (van Beek-Harmsen and van der
Laarse  2005) and production of ROS (Lee et al. 2006;
Powers et al. 2007) and eventually causing apoptosis of
cardiac myocytes. The importance of the IGF-2/IGFbp1
signaling in the protection of the zebraWsh heart and its
underlying mechanisms remain to be determined.
The gene expression changes we observed for the spe-
ciWc response to CCH in the Wsh heart were very diVerent
from the responses we observed in an earlier study in the
gills (van der Meer et al. 2005). Under the same criteria as
used in this study, we found that the majority of diVeren-
tially regulated genes in the gills showed a decrease in gene
expression (68.1% or 250 genes in total) in comparison toJ Comp Physiol B (2008) 178:77–92 91
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genes, which showed increased expression levels (31.9% or
117 genes in total). This is opposed to the heart where
69.1% of diVerentially regulated genes (260 genes in total)
showed increased and 30.9% (116 in total) decreased
expression levels. Many genes linked to protein synthesis
showed a similar trend, and were downregulated in the gills
(van der Meer et al. 2005) and upregulated in the heart
(Table 2). The major diVerences observed in gene regula-
tion between heart and gills point to very tissue speciWc
responses to CCH. A list of genes identiWed in both studies,
as identiWed by a direct comparison based on Accession
numbers and old Unigenes numbers are shown in Supple-
mental Data 3.
Teleosts have developed speciWc phenotypic adaptations
to low oxygen, due to the natural occurrence of hypoxia in
the water environment. Here, we identiWed the changes in
gene expression as well as associated morphological
changes of the Wsh heart to hypoxia. We observed repres-
sion of c-fos, which diVers compared to the described
increase in expression in mammals (Deindl et al. 2003).
Other changes found like upregulation of the two Notch
receptors have not been described before to the best of our
knowledge. Similarly, the simultaneous increase in expres-
sion of IGF-2 and IGFbp1 has not been shown. The
changes identiWed here can contribute to the ability of tele-
osts to adapt to severe hypoxia (for example, the upregula-
tion of fetuin- and sepp1 levels). Future functional studies
are warranted to validate the role of the identiWed genes in
cardiac protection to hypoxia.
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